Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant in Patients With High Risk Locallized Prostate Cancer
The purpose of this study is to evaluate whether neoajuvant and adjuvant docetaxel and
prednisone are effective in the treatment of high risk localized prostate cancer.
Interventional
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label
biochemical recurrence rate of Radical Prostatectomy Combined with Neoadjuvant and Adjuvant Chemotherapy in Patients with High Risk Prostate Cancer
2 Years After RRP
Yes
hanjong Ahn, Ph.D
Principal Investigator
Asan Medical Center
Korea: Food and Drug Administration
2007-0326
NCT01530295
July 2008
July 2012
Name | Location |
---|